14 October 2013 08:04 [Source: ICIS news]
SINGAPORE (ICIS)--Roche is planning to invest Swiss francs (Swfr) 800m ($888m) to expand its production capabilities for biologic medicines over the next five years, the Swiss pharmaceuticals firm said on Monday.
The investment will involve sites at Penzberg in Germany, Basel in Switzerland as well as Vacaville and Oceanside in the US, it said in a statement.
The facility expansions will create about 500 new jobs, it added.
($1 = Swfr0.90)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections